drugdeliverybusiness13d
Medtronic to submit MiniMed 780G to FDA for type 2 diabetes in 2025, updates on patch pump
Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.
FierceBiotech12d
Medtronic scores FDA clearance for smart insulin pen app aimed at multiple daily injections
With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete ...